Yong‐Cheng Ma

708 total citations
19 papers, 630 citations indexed

About

Yong‐Cheng Ma is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Yong‐Cheng Ma has authored 19 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in Yong‐Cheng Ma's work include Catalytic C–H Functionalization Methods (6 papers), Bioactive Natural Diterpenoids Research (6 papers) and Cell death mechanisms and regulation (4 papers). Yong‐Cheng Ma is often cited by papers focused on Catalytic C–H Functionalization Methods (6 papers), Bioactive Natural Diterpenoids Research (6 papers) and Cell death mechanisms and regulation (4 papers). Yong‐Cheng Ma collaborates with scholars based in China, United States and Australia. Yong‐Cheng Ma's co-authors include Hong‐Min Liu, Ying‐Chao Duan, Xiaojing Shi, En Zhang, Mengmeng Wang, Xian-Wei Ye, Tao Guo, Yingli Zhu, Yu Ke and Yun‐Hui Zhao and has published in prestigious journals such as Sensors and Actuators B Chemical, Antioxidants and Redox Signaling and European Journal of Pharmacology.

In The Last Decade

Yong‐Cheng Ma

19 papers receiving 624 citations

Peers

Countries citing papers authored by Yong‐Cheng Ma

Since Specialization

Citations

This map shows the geographic impact of Yong‐Cheng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong‐Cheng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong‐Cheng Ma more than expected).

Fields of papers citing papers by Yong‐Cheng Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong‐Cheng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong‐Cheng Ma. The network helps show where Yong‐Cheng Ma may publish in the future.

Co-authorship network of co-authors of Yong‐Cheng Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Yong‐Cheng Ma. A scholar is included among the top collaborators of Yong‐Cheng Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong‐Cheng Ma. Yong‐Cheng Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Optimization of CRISPR/Cas12f1 guide RNAs using AlphaFold 3 for enhanced nucleic acid detection 2025 ·Microchemical Journal ·Lulu Pan, Yong‐Cheng Ma, Rui Sang, Lu Xia, (unknown), Ming Li, (unknown), Aifeng Wang, Fei Deng	3
2	AlphaFold 3 sheds insights into chemical enhancer-induced structural changes in Cas12a RNPs 2025 ·UNSWorks (University of New South Wales, Sydney, Australia) ·Lulu Pan, Aifeng Wang, Rui Sang, Lu Xia, Wenjie Chen, Yong‐Cheng Ma, Fei Deng	1
3	T‐2 toxin cytotoxicity mediated by directly perturbing mitochondria in human gastric epithelium GES‐1 cells 2020 ·Journal of Applied Toxicology ·Nan‐Wei Su, (unknown), (unknown), (unknown), Yong‐Cheng Ma	11
4	Highly Efficient and Eco‐Benign Synthesis of 3‐Imidazoheterocyclic‐Substituted Phthalides/Isoindolinones in Water under Catalyst‐ and Additive‐Free Conditions 2020 ·European Journal of Organic Chemistry ·Tao Guo, Huijie Wang, (unknown), (unknown), Yu Liu, Panke Zhang, Yun‐Hui Zhao, Yong‐Cheng Ma	5
5	A novel ent-kaurane diterpenoid analog, DN3, selectively kills human gastric cancer cells via acting directly on mitochondria 2019 ·European Journal of Pharmacology ·Yong‐Cheng Ma, (unknown), Nan Su, Yu Ke, (unknown), Xiaojing Shi, Hong‐Min Liu, Aifeng Wang	12
6	Catalyst-free direct cross-dehydrogenative coupling of imidazoheterocycles with glyoxal hydrates: an efficient approach to 1,2-diketones 2019 ·Organic & Biomolecular Chemistry ·Tao Guo, (unknown), Miao Zhang, (unknown), Yong‐Cheng Ma	17
7	Synthesis of Potential Anticancer 1-(1H-Indol-3-yl)isoquinolines by Silver Nitrate Mediated Tandem Reactions of 2-Alkynylbenzaldehyde Azines and Indoles 2018 ·Synlett ·Yun‐Hui Zhao, Zhihua Zhou, Yong‐Cheng Ma, (unknown), Yingli Zhu, Hang Wang, (unknown), (unknown), Wenlin Xie, Zilong Tang	37
8	Copper-Catalyzed One-Pot Synthesis of Chalcogen-Benzothiazoles/Imidazo[1,2-a]pyridines with Sulfur/Selenium Powder and Aryl Boronic Acids 2018 ·Synlett ·Tao Guo, Shulei Han, Yong‐Cheng Ma, (unknown), Yingli Zhu, Huan Chen	27
9	Highly sensitive bifunctional sensor of a dinuclear terbium complex 2018 ·Sensors and Actuators B Chemical ·Fei Zhao, Xuezheng Wang, (unknown), Peizhi Ma, Wei Zhang, Yong‐Cheng Ma, (unknown), Jun Sun	27
10	Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment 2017 ·European Journal of Medicinal Chemistry ·Ying‐Chao Duan, Yong‐Cheng Ma, (unknown), Lina Ding, Yi‐Chao Zheng, (unknown), Xiaoyu Zhai, Jing Yang, (unknown), Yuanyuan Guan	70
11	Copper-catalyzed chalcogenation of imidazoheterocycles with sulfur/selenium powder and coumarinyl triflates 2017 ·Organic & Biomolecular Chemistry ·Tao Guo, (unknown), Hongyan Wang, Yingli Zhu, Yun‐Hui Zhao, Yong‐Cheng Ma	54
12	Pro-Apoptotic Effects of JDA-202, a Novel Natural Diterpenoid, on Esophageal Cancer Through Targeting Peroxiredoxin I 2016 ·Antioxidants and Redox Signaling ·Xiaojing Shi, Lina Ding, Wenjuan Zhou, (unknown), Junwei Wang, Huimin Wang, Yong‐Cheng Ma, Guozhong Jiang, Kai Tang, Yu Ke, Wen Zhao, Hong‐Min Liu	26
13	[Jaridonin, a new diterpenoid from Isodon rubescens, induces cell cycle arrest in gastric cancer cells through activating ataxia telangiectasia mutated kinase]. 2016 ·PubMed ·Yong‐Cheng Ma, Nan Su, (unknown), Qiaoyan Li, Meng Zhang, Hongwei Zhao, Hong‐Min Liu, Yuhua Qin	1
14	Induction of the mitochondria-mediated apoptosis in human esophageal cancer cells by DS2, a newly synthetic diterpenoid analog, is regulated by Bax and caused by generation of reactive oxygen species 2016 ·Oncotarget ·Yong‐Cheng Ma, Yu Ke, Xiaolin Zi, Fei Zhao, Lin Yuan, (unknown), (unknown), (unknown), (unknown), Yuhua Qin, Hong‐Min Liu	22
15	ALDH22 Allele is a Negative Risk Factor for Cerebral Infarction in Chinese Women 2015 ·Biochemical Genetics* ·(unknown), (unknown), Jianjun Ma, (unknown), Yong‐Cheng Ma, Wei Zhang, Hongwei Zhao, Yuhua Qin	13
16	Individuals having variant genotypes of cytochrome P450 2C19 are at increased risk of developing primary liver cancer in Han populations, without infection with the hepatitis virus 2014 ·Tumor Biology ·(unknown), (unknown), Liancai Wang, (unknown), Yong‐Cheng Ma, Wei Zhang, Hongwei Zhao, Yuhua Qin	3
17	Jaridonin-induced G2/M phase arrest in human esophageal cancer cells is caused by reactive oxygen species-dependent Cdc2-tyr15 phosphorylation via ATM–Chk1/2–Cdc25C pathway 2014 ·Toxicology and Applied Pharmacology ·Yong‐Cheng Ma, Nan Su, Xiaojing Shi, Wen Zhao, Yu Ke, Xiaolin Zi, (unknown), Yuhua Qin, Hongwei Zhao, Hong‐Min Liu	38
18	Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents 2013 ·European Journal of Medicinal Chemistry ·Ying‐Chao Duan, Yong‐Cheng Ma, En Zhang, Xiaojing Shi, Mengmeng Wang, Xian-Wei Ye, Hong‐Min Liu	229
19	Jaridonin, a Novel Ent-Kaurene Diterpenoid from Isodon rubescens, Inducing Apoptosis via Production of Reactive Oxygen Species in Esophageal Cancer Cells 2013 ·Current Cancer Drug Targets ·Yong‐Cheng Ma, Yu Ke, Xiaolin Zi, Wen Zhao, Xiaojing Shi, Hong‐Min Liu	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact